Alumis ALMS
NASDAQ ALMS
$11.08 -0.28 (-2.46%)
As of: Sep 4, 2026 · 1:36 PM EDT

Alumis (ALMS) Change in Accured Expenses (2023 - 2025)

Alumis (ALMS) posted quarterly Change in Accured Expenses of $3.5 million for Q4 2025, up 11.75% year-over-year from $3.1 million in Q4 2024, and up 187.42% quarter-over-quarter from -$4.0 million in Q3 2025.

Analysis

Alumis (ALMS) Change in Accured Expenses (2023 - 2025) Analysis & Trends

Alumis (ALMS) has reported Change in Accured Expenses for 3 consecutive years, with $3.5 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Change in Accured Expenses rose 11.75% year-over-year to $3.5 million; the TTM figure through Dec 2025 stood at $6.0 million (up 70.41% YoY), while the FY2025 annual figure was $6.0 million, up 70.41% from the prior year.
  • Change in Accured Expenses advanced to $3.5 million in Q4 2025 per ALMS's latest filing, from -$4.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $5.0 million in Q1 2025 and bottomed at -$4.0 million in Q3 2025.
  • Historically, Change in Accured Expenses has averaged $1.2 million across 3 years, with a median of $1.6 million in 2023.
  • On a YoY basis, Change in Accured Expenses climbed as much as 255.29% in 2025 and fell as far as 270.36% in 2025.
  • Alumis' Change in Accured Expenses stood at $1.6 million in 2023, then soared by 91.64% to $3.1 million in 2024, then climbed by 11.75% to $3.5 million in 2025.
  • Business Quant data shows ALMS's Change in Accured Expenses at $3.5 million in Q4 2025, -$4.0 million in Q3 2025, and $1.5 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 55.78 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 68.82 Mn
10 Alumis 1.42 Bn 917.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.48 Mn
Sep 30, 2025 -3.98 Mn
Jun 30, 2025 1.55 Mn
Mar 31, 2025 4.99 Mn
Dec 31, 2024 3.12 Mn
Sep 30, 2024 2.34 Mn
Jun 30, 2024 1.30 Mn
Mar 31, 2024 -3.21 Mn
Dec 31, 2023 1.63 Mn
Sep 30, 2023 1.11 Mn